ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0783

Transmission Disequilibrium Testing Meets Next Generation Sequencing: Applying TDT to Whole Genome Data in Childhood-Onset Systemic Lupus Erythematosus

Kathleen Vazzana1, Anthony Musolf2, Joan Bailey-Wilson3, Zuoming Deng3, Mariana Kaplan3 and Laura Lewandowski2, 1National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)/Children's National Hospital, Washington, DC, 2NIAMS, NIH, Rockville, MD, 3National Institutes of Health, Bethesda, MD

Meeting: ACR Convergence 2021

Keywords: genetics, Lupus, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Pediatric Rheumatology – Clinical Poster II: SLE, JDM, & Juvenile Scleroderma (0764–0785)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder that is more severe in children than adults. Due to aggressive disease in childhood-onset SLE (cSLE), identification of genetic associations in this population could lead to insights into pathogenesis. Transmission disequilibrium test (TDT) is a family-based genetic association test performed on trios (affected patient and two unaffected parents) to compare the rate of transmission of an associated marker allele from the heterozygous parent to an affected offspring. Trio based TDT has increased power to detect association over a wide range of allele frequencies, but the empirical significance threshold has not been established for whole genome data. This is the first study to apply TDT to whole genome sequence data in a diverse, international cSLE cohort.

Methods: SLE subjects met at least 4 of 11 revised American College of Rheumatology classification SLE criteria. cSLE subjects had disease onset prior to age 18. Whole blood samples collected from 81 subjects and 111 parents underwent whole genome sequencing via Illumina HiSeq X Ten. TDT was performed to assess for association of each variant allele with cSLE in the parents with heterozygous genotypes. TDT was performed as SNP-based and gene-based analyses. SNP-based TDT was performed using PLINK 1.9. Gene-based TDT analyses used EPACTS to annotate each SNP into genes. We then employed rvTDT, which uses multiple gene-based burden tests adapted for TDT including the burden of rare variants (BRV) test. Statistical significance was determined empirically by permutation for both the SNP-based and gene-based analyses.

Results: The SNP-based analysis did not return any genome-wide significant SNPs. A SNP of interest close to the empirical significance threshold was found to be associated with the Transmembrane Protein 132C gene (TMEM132C). In the gene-based TDT analysis, many significant genes were identified (Table 1). We cross-referenced our SNP and gene-based results with results from other SLE genetic analysis. TMEM132C was also present in our gene-based analysis, although again it did not reach statistical significance. The TMEM132 family encodes for cell to cell junctions in the central nervous system. TMEM132C has not been associated with autoimmunity in prior studies, but previous genome wide association studies have found this gene to be associated with panic disorder, oncologic conditions, and hearing loss.

Conclusion: Our study identified novel genetic mutations that were statistically significant in a diverse childhood-onset lupus cohort. While no SNP reached significance across the genome, when we clustered SNPs by gene, we found many unrelated families were enriched in variants in the same gene. Future studies should be done to explore the role of TMEM132C in the pathogenesis of SLE. Our study is the first in rheumatology to apply TDT methodology to whole genome data. TDT methodology allowed for a robust analysis in a diverse patient cohort. Further studies in larger cohort of cSLE patient/parent trios will allow us to better evaluate significant SNP- and gene-based associations and identify candidate causal risk genes for SLE.

Table 1. Top gene based rvTDT results.


Disclosures: K. Vazzana, None; A. Musolf, None; J. Bailey-Wilson, None; Z. Deng, None; M. Kaplan, None; L. Lewandowski, None.

To cite this abstract in AMA style:

Vazzana K, Musolf A, Bailey-Wilson J, Deng Z, Kaplan M, Lewandowski L. Transmission Disequilibrium Testing Meets Next Generation Sequencing: Applying TDT to Whole Genome Data in Childhood-Onset Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/transmission-disequilibrium-testing-meets-next-generation-sequencing-applying-tdt-to-whole-genome-data-in-childhood-onset-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transmission-disequilibrium-testing-meets-next-generation-sequencing-applying-tdt-to-whole-genome-data-in-childhood-onset-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology